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Background: Percutaneous coronary interventions involving small coronary vessels represent a true challenge because of the increased risk 
of restenosis and adverse outcomes. The aim of this study is to evaluate the one-year clinical results following small coronary stenting between 
everolimus- (EES) and paclitaxel-eluting stent (PES). 
methods: PLUM (PROMUS/Xience V Everolimus-ELUting Coronary Stent for sMall coronary artery disease: 264 patients with 279 lesions) and 
SACRA (SmAll CoronaRy Artery treated by TAXUS Liberté: 245 patients with 258 lesions) registries are prospective, multicenter registries to assess the 
efficacy of single EES and PES in patients with small coronary artery diseases. Inclusion criteria were 1) Lesions >75% diameter stenosis in vessels 
<2.5mm in diameter, 2) lesion length <28mm. The primary endpoint is clinical driven target lesion revascularization (TLR) rate at one year. 
results: Major adverse cardiac events between the two groups were similar, however, one year TLR rate was significantly lower in EES group (Table). 
conclusions: EES showed better clinical and angiographic results for treatment of small coronary artery diseases.
One year clinical and angiographic results
EES PES p
Acute gain, mm 1.37±0.36 1.40±0.29 0.2
Late loss, mm 0.24±0.29 0.50±0.46 <0.0001
Binary restenosis rate 5.0% 11.1% 0.02
Cardiac death 0.4% 0.4% -
Myocardial Infarction 1.2% 0.4% -
TLR 4.1% 9.6% 0.01
TVR 10.0% 12.4% 0.34
Any MACE 10.7% 12.7% 0.50
